5-Bromo-2-iodopyridine | CAS:223463-13-6

We serve 5-Bromo-2-iodopyridine CAS:223463-13-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
5-Bromo-2-iodopyridine

Chemical Name:5-Bromo-2-iodopyridine
CAS.NO:223463-13-6
Synonyms:5-BROMO-2-IDIOPYRIDINE; 
5-Bromo-2-Iodopyridine; 
3-bromo-6-iodopyridine; 
2-IODO-5-BROMOPYRIDINE; 
2-iodo-5-bromo-pyridine;
Molecular Formula:C5H3BrIN
Molecular Weight:283.89200
 
Physical and Chemical Properties:
Density:2.347;
Melting point:113-117oC;
Boiling point:258.8oC;
Index of Refraction:1.665;
 
Specification:
Appearance:Light brown to brown crystalline powder
Purity(GC):≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate for organic synthesis
 



Contact us for information like 5-Bromo-2-iodopyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-iodo-5-bromo-pyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-IODO-5-BROMOPYRIDINE Use and application,2-IODO-5-BROMOPYRIDINE technical grade,usp/ep/jp grade.


Related News: The two institutes that discovered Shuanghuanglian’s alleged ability to “inhibit” the coronavirus are both state-run bodies.[(6-chlorobenzotriazol-1-yl)oxy-(dimethylamino)methylidene]-dimethylazanium,hexafluorophosphate manufacturer Featured APIs: Production capacity continues to expand, targeted patents expire. Original research drugs: industry entry barriers are high, performance stability and certainty are high.2-Bromo-3-fluoropyridine supplier Featured APIs: Production capacity continues to expand, targeted patents expire. Original research drugs: industry entry barriers are high, performance stability and certainty are high.4-Amino-3-nitropyridine vendor According to the “2013-2018 New Drug Review Summary” report, from 2013 to 2018, new drug applications have shown a year-on-year growth trend. In 2018, domestically produced Class 1 new drugs have declared 225 varieties, the highest in 10 years.Another prominent coronavirus to emerge since the turn of the century is Middle East respiratory syndrome (MERS), which was first identified in Saudi Arabia in 2012 and killed more than 800 people.